Roche (RHHBY) News Today $38.84 -0.07 (-0.18%) As of 08/1/2025 03:59 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartDividendHeadlinesInsider TradesOwnershipShort InterestBuy This Stock RHHBY Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Roche’s Susvimo maintains vision over five years with two refills per year in people with neovascular age-related macular degeneration (nAMD)August 1 at 2:56 PM | finance.yahoo.comGenentech's Susvimo Maintains Vision Over Five Years With Two Refills Per Year in People With Wet Age-Related Macular Degeneration (AMD)August 1 at 2:00 PM | businesswire.comRoche's Susvimo maintains vision over five years with two refills per year in people with neovascular age-related macular degeneration (nAMD)August 1 at 2:00 PM | globenewswire.comReviewing Sanofi (NASDAQ:SNY) and Roche (OTCMKTS:RHHBY)August 1 at 3:49 AM | americanbankingnews.comAnalyst Report: Roche Holding AGJuly 30 at 5:47 PM | finance.yahoo.comRoche Holding AG’s Earnings Call Highlights Growth and ChallengesJuly 30 at 8:13 AM | theglobeandmail.comDZ BANK AG Reaffirms Their Buy Rating on Roche Holding AG (RHHVF)July 28, 2025 | theglobeandmail.comGenentech to present new data from Alzheimer’s development portfolioJuly 28, 2025 | msn.comEU-US trade deal could add up to $19 billion in pharma industry costs, analysts sayJuly 28, 2025 | reuters.comRoche plans to test if new medicine can prevent AD symptoms, Bloomberg saysJuly 28, 2025 | msn.comGenentech and Roche Present New Insights in Alzheimer's Disease Research Across Its Diagnostics and Pharmaceutical Portfolios at AAICJuly 28, 2025 | businesswire.comRoche presents new insights in Alzheimer's disease research across its diagnostics and pharmaceutical portfolios at AAICJuly 28, 2025 | globenewswire.comRoche to test if new drug can prevent Alzheimer's disease, Bloomberg News reportsJuly 27, 2025 | reuters.comHead to Head Contrast: Innoviva (NASDAQ:INVA) vs. Roche (OTCMKTS:RHHBY)July 26, 2025 | americanbankingnews.comHead-To-Head Comparison: Merck & Co., Inc. (NYSE:MRK) versus Roche (OTCMKTS:RHHBY)July 26, 2025 | americanbankingnews.comEU panel declines backing Sarepta-Roche gene therapy for DuchenneJuly 25, 2025 | msn.comRoche Holding AG (RHHBY) Q2 2025 Earnings Call TranscriptJuly 25, 2025 | seekingalpha.comRoche pauses Sarepta gene therapy shipments outside the U.S.July 24, 2025 | msn.comRoche eyes direct-to-patient sales in U.S. to avoid pharma middlemenJuly 24, 2025 | msn.comRoche: Q2 Earnings - Pipeline Setbacks And U.S. Pressures Undermine Solid ResultsJuly 24, 2025 | seekingalpha.comRoche Diagnostics showcases science-driven leadership and innovation at ADLM 2025July 24, 2025 | prnewswire.comRoche Holding AG: Hold Rating Amid Mixed Financial Signals and Strategic ChallengesJuly 24, 2025 | tipranks.comRoche considering selling drugs directly to US patients, CEO saysJuly 24, 2025 | reuters.comRoche confirms guidance as H1 core operating profit up 6%July 24, 2025 | reuters.com[Ad hoc announcement pursuant to Art. 53 LR] Roche continues strong momentum with 7% growth (CER) in the first half of 2025July 24, 2025 | globenewswire.comThe Roche Associates, Inc. Named “Top Senior Living Marketing Agency 2025”July 23, 2025 | globenewswire.comEuropean Commission approves Roche’s Itovebi for people with ER-positive, HER2-negative, advanced breast cancer with a PIK3CA mutationJuly 23, 2025 | finance.yahoo.comRoche receives CE Mark for minimally invasive blood test to help rule out Alzheimer's diseaseJuly 23, 2025 | globenewswire.comEuropean Commission approves Roche's Itovebi for people with ER-positive, HER2-negative, advanced breast cancer with a PIK3CA mutationJuly 23, 2025 | globenewswire.comEWL: Buy Swiss, Invest GloballyJuly 22, 2025 | seekingalpha.comRoche’s Board of Directors proposes exchange of Genussscheine for participation certificates (Partizipationsscheine)July 22, 2025 | uk.finance.yahoo.comSarepta pares gains as report suggests an ‘arduous’ path for Duchenne drugJuly 22, 2025 | msn.comRoche pauses shipments of Elevidys gene therapy outside the US, Bloomberg News reportsJuly 22, 2025 | reuters.comRoche's Board of Directors proposes exchange of Genussscheine for participation certificates (Partizipationsscheine)July 22, 2025 | globenewswire.comRoche COPD biologic astegolimab fails in phase 3 for COPDJuly 21, 2025 | msn.com[Ad hoc announcement pursuant to Art. 53 LR] Roche provides update on astegolimab in chronic obstructive pulmonary diseaseJuly 21, 2025 | globenewswire.comGenentech Provides Update on Astegolimab in Chronic Obstructive Pulmonary DiseaseJuly 21, 2025 | businesswire.comSarepta to continue Elevidys shipments despite FDA request to haltJuly 19, 2025 | msn.comSarepta plunges as FDA is reportedly evaluating if gene therapy should remain on marketJuly 18, 2025 | msn.comGenentech Provides Update on Supplemental Biologics License Application for Columvi Combination for People With Relapsed or Refractory Diffuse Large B-cell LymphomaJuly 18, 2025 | businesswire.comSarepta plunges after third patient death tied to gene therapy - reportJuly 18, 2025 | msn.comRoche Holding AG (OTCMKTS:RHHBY) Receives Average Recommendation of "Moderate Buy" from BrokeragesJuly 12, 2025 | marketbeat.comPharma Companies Remain Calm Amid Fresh Tariff Threat by TrumpJuly 11, 2025 | theglobeandmail.comRoche Holding AG (OTCMKTS:RHHBY) Shares Bought by Moloney Securities Asset Management LLCJuly 9, 2025 | marketbeat.comRHHBY - Roche Holding AG ADR Sustainability - MorningstarJuly 8, 2025 | morningstar.comMRHHBY - Roche Holding AG ADR Chart - MorningstarJuly 3, 2025 | morningstar.comMChanges to the Roche Enlarged Corporate Executive CommitteeJune 30, 2025 | globenewswire.comRHHBY - Roche Holding AG ADR Trailing Returns - MorningstarJune 27, 2025 | morningstar.comMRHHBY Roche Holding AG - Seeking AlphaJune 27, 2025 | seekingalpha.comRHHBY - Roche Holding AG ADR Key Metrics - MorningstarJune 25, 2025 | morningstar.comM Get Roche News Delivered to You Automatically Sign up to receive the latest news and ratings for RHHBY and its competitors with MarketBeat's FREE daily newsletter. Email Address RHHBY Media Mentions By Week RHHBY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RHHBY News Sentiment▼0.190.63▲Average Medical News Sentiment RHHBY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RHHBY Articles This Week▼169▲RHHBY Articles Average Week Get Roche News Delivered to You Automatically Sign up to receive the latest news and ratings for RHHBY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies China Construction Bank News Airbus Group News EssilorLuxottica News Iberdrola News Nintendo News BNP Paribas News Vinci News Atlas Copco News Compass Group News Bayerische Motoren Werke News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:RHHBY) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roche Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Roche With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RHHBY Stock Alerts